U.S. Health Agencies Will Decide if COVID-19 Booster Shots Are Needed — Not Vaccine Companies
With coronavirus variants popping up across the globe, new questions are beginning to arise about how long the immunity from the vaccines will last, and whether booster shots will be needed to maintain protection against the mutating virus.
Although vaccine companies are already in the process of conducting clinical trials for booster shots, and preparing for potential widespread distribution, a decision pertaining to if and when the updated shots will be needed in the months and years to come will ultimately be made by a team of independent scientists and U.S. government officials.
More Deaths Reported After J&J, AstraZeneca Vaccines, Plus Researchers Link AstraZeneca to Strokes in Young Adults
The AstraZeneca and Johnson & Johnson (J&J) COVID vaccines came under scrutiny again this week as more reports of deaths — largely due to blood clot disorders — surfaced in Belgium, Canada and Greece.
Adding to the vaccine makers’ woes is a new report out of London from researchers who identified the first cases of strokes occurring in young adults who received the AstraZeneca vaccine, which was co-developed by the University of Oxford University in the UK.
‘This Week’ With Mary + Polly: Newspaper Editor Says ‘Anti-Vaxxers’ Should Be Denied Access to Healthcare + More
This week, Mary Holland, Children’s Health Defense (CHD) president, and Polly Tommey, co-producer of “Vaxxed,” cover the latest COVID headlines, including new research suggesting the number of children hospitalized for COVID is overcounted, a letter from UK medical professionals expressing “grave concern” about vaccinating schoolchildren for COVID and a CDC investigation linking the COVID vaccine to heart problems in teens and young adults.
Moderna Seeks Expanded Covid-19 Vaccine EUA
Moderna will seek to expand the emergency use authorization (EUA) for their COVID-19 vaccine to children after it showed high efficacy in a study.
According to a news release, the phase 2/3 study of the vaccine in adolescents met its primary immunogenicity endpoint. It proved to have 93% efficacy 14 days after the first dose. The company plans to submit the data to global regulator in early June.
Two West Aussies the Latest to Develop Blood Clots
A man and a woman from Western Australia are the latest people to get a blood clot after receiving the AstraZeneca vaccine.
The woman in her 50’s is recovering in a Perth hospital, while the man in his 70’s is at home.
Both cases are being investigated by the state’s health department and Australia’s drug regulator.
Nine instances of blood clots and low blood platelets have been reported nationwide in connection with the AstraZeneca vaccine in the past week, the Therapeutical Goods Administration (TGA) has announced.
Six reports have been confirmed as linked to the vaccine, while three more instances are considered probable.
The confirmed cases are two women in NSW aged 60 and 82, a 72-year-old man from WA, a 51-year-old WA woman, a 73-year-old Victorian woman and a 63-year-old Queensland man.
Eli Lilly Hit With DOJ Subpoena Over New Jersey Factory Making COVID-19 Drug
Earlier this month, Eli Lilly’s COVID-19 drug factory in New Jersey garnered unwanted headlines for quality control snafus and alleged document tampering. Now, the Department of Justice (DOJ) has stepped in to investigate.
Thursday, Lilly revealed the DOJ has issued a subpoena demanding documents relating to the site in Branchburg, New Jersey. The site produces doses of Lilly’s COVID-19 antibody treatment, which has recently faced setbacks for its susceptibility to certain variants.
The post appeared first on Children’s Health Defense.
This content was originally published here.